AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc.
1100 Winter Street
Waltham, MA 02451
Phone: (617) 498-3300Website: https://www.amagpharma.com/Careers: www.amagpharma.com/working-at-amag

Latest news

AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
21 June 2019
Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
4 June 2018
Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
26 March 2018
Advanced Magnetics, Inc. Receives Approvable Letter From FDA For Combidex
24 March 2005
Oncologic Drugs Advisory Committee Recommends Against Approval of a Broad Indication For Combidex
3 March 2005
Advanced Magnetics' Combidex to be Reviewed by FDA Oncologic Drugs Advisory Committee
1 February 2005

Drugs Associated with AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 3 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.

Brand/Generic Name	Reviews	Rating
Feraheme Generic name: ferumoxytol Drug class: iron products	8 reviews	7.4 / 10
Intrarosa Generic name: dehydroepiandrosterone	96 reviews	5.1 / 10
Vyleesi Generic name: bremelanotide Drug class: melanocortin receptor agonists	24 reviews	7.8 / 10
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Discontinued Drugs

Brand/Generic Name	Reviews	Rating
Makena Generic name: hydroxyprogesterone Drug class: progestins	134 reviews	6.8 / 10
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).